Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low-and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)

Circulation

Volumn 134, Issue 19, 2016, Pages 1456-1466

  Zühlke, Liesl ^a,b   Karthikeyan, Ganesan ^c   Engel, Mark E ^a   Rangarajan, Sumathy ^d   Mackie, Pam ^d   Cupido Katya Mauff, Blanche ^a   Islam, Shofiqul ^d   Daniels, Rezeen ^a   Francis, Veronica ^a   Ogendo, Stephen ^e   Gitura, Bernard ^f   Mondo, Charles ^g   Okello, Emmy ^h   Lwabi, Peter ^h   Al Kebsi, Mohammed M ^b,i   Hugo Hamman, Christopher ^b,j   Sheta, Sahar S ^k   Haileamlak, Abraham ^l   Daniel, Wandimu ^l   Goshu, Dejuma Yadeta ^m   Abdissa, Senbeta G ^m   Desta, Araya G ^m   Shasho, Bekele A ^m   Begna, Dufera M ^m   Elsayed, Ahmed ⁿ   Ibrahim, Ahmed S ⁿ   Musuku, John ^o   Bode Thomas, Fidelia ^p   Yilgwan, Christopher C ^p   Amusa, Ganiyu A ^p   Ige, Olukemi ^p   Okeahialam, Basil ^p   Sutton, Christopher ^q   Misra, Rajeev ^q   Abul Fadl, Azza ^r   Kennedy, Neil ^s   Damasceno, Albertino ^t   Sani, Mahmoud U ^u   Ogah, Okechukwu S ^v,w,x   Elhassan, Taiwo Olunugahuda H M ^x,y   Mocumbi, Ana Olga ^z   Adeoye, Abiodun M ^v   Mntla, Phindile ^aa   Ojji, Dike ^ab   Mucumbitsi, Joseph ^ac   Teo, Koon ^d   Yusuf, Salim ^d   Mayosi, Bongani M ^a   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Kenyatta National Teaching and Referral Hospital   (Kenya)

^g MULAGO HOSPITAL   (Uganda)

^h UGANDA HEART INSTITUTE   (Uganda)

ⁱ SANA A UNIVERSITY   (Yemen)

^j Windhoek Central Hospital   (Namibia)

^k CAIRO UNIVERSITY   (Egypt)

^l JIMMA UNIVERSITY   (Ethiopia)

^m ADDIS ABABA UNIVERSITY   (Ethiopia)

ⁿ ALZAIEM ALAZHARI UNIVERSITY   (Sudan)

^o UNIVERSITY TEACHING HOSPITAL   (Zambia)

^p UNIVERSITY OF JOS   (Nigeria)

^q UNIVERSITY OF LIMPOPO   (South Africa)

^r BENHA UNIVERSITY   (Egypt)

^s UNIVERSITY OF MALAWI   (Malawi)

^t EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^u AMINU KANO TEACHING HOSPITAL   (Nigeria)

^v UNIVERSITY OF IBADAN   (Nigeria)

^w Ministry of Health   (Nigeria)

^x FEDERAL MEDICAL CENTER   (Nigeria)

^y Ahmed Gasim Teaching Hospital   (Sudan)

^z INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^aa Dr George Mukhari Hospital and Sefako Makgatho Health Sciences University   (South Africa)

^ab UNIVERSITY OF ABUJA   (Nigeria)

^ac KING FAISAL HOSPITAL   (Rwanda)

more..

Author keywords

countries; Developing; heart; morbidity; mortality; outcome assessment; patient; rheumatic heart disease; valves

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGE; ARTICLE; ASIA; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CASE FATALITY RATE; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONGESTIVE HEART FAILURE; EDUCATIONAL STATUS; ENDOCARDITIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MIDDLE INCOME GROUP; MORTALITY RATE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; RECURRENT DISEASE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; CLINICAL TRIAL; DEVELOPING COUNTRY; EPIDEMIOLOGY; HEART FAILURE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REGISTER;

ADOLESCENT; ADULT; AFRICA; AGE FACTORS; ASIA; DEVELOPING COUNTRIES; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RHEUMATIC HEART DISEASE; STROKE;

EID: 84991465866     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.024769     Document Type: Article

References (36)

1. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379:953-964. doi: 10.1016/S0140-6736(11)61171-9.
2. Naghavi M, Wang HD, Lozano R, Davis A, Liang XF, Zhou MG, Vollset SE, Ozgoren AA, Abdalla S, Abd-Allah F, Aziz MIA, Abera SF, Aboyans V, Abraham B, Abraham JP, Abuabara KE, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NME, Achoki T, Adelekan A, Ademi ZN, Adofo K, Adou AK, Adsuar JC, Arnlov J, Agardh EE, Akena D, Al Khabouri MJ, Alasfoor D, Albittar M, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali MK, Ali R, Alla F, Al Lami F, Allebeck P, AlMazroa MA, Salman RAS, Alsharif U, Alvarez E, Alviz-Guzman N, Amankwaa AA, Amare AT, Ameli O, Amini H, Ammar W, Anderson HR, Anderson BO, Antonio CAT, Anwari P, Apfel H, Cunningham SA, Arsenijevic VSA, Al A, Asad MM, Asghar RJ, Assadi R, Atkins LS, Atkinson C, Badawi A, Bahit MC, Bakfalouni T, Balakrishnan K, Balalla S, Banerjee A, Barber RM, Barker-Collo SL, Barquera S, Barregard L, Barrero LH, Barrientos-Gutierrez T, Basu A, Basu S, Basulaiman MO, Beardsley J, Bedi N, Beghi E, Bekele T, Bell ML, Benjet C, Bennett DA, Bensenor IM, Benzian H, Bertozzi-Villa A, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bikbov B, Bin Abdulhak A, Biryukov S, Blore JD, Blyth FM, Bohensky MA, et al. of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-171.
3. Karthikeyan G, Zühlke L, Engel M, Rangarajan S, Yusuf S, Teo K, Mayosi BM. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am Heart J. 2012;163:535-540.e1. doi: 10.1016/j.ahj.2012.01.003.
4. Bland EF, Duckett Jones T. Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood. Circulation. 1951;4:836-843.
5. The natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation. 1965;32:457-476.
6. Milne RJ, Lennon D, Stewart JM, Vander Hoorn S, Scuffham PA. Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J Paediatr Child Health. 2012;48:692-697. doi: 10.1111/j.1440-1754.2012.02446.x.
7. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation. 2013;128:492-501. doi: 10.1161/CIRCULATIONAHA.113.001477.
8. He VY, Condon JR, Ralph AP, Zhao Y, Roberts K, de Dassel JL, Currie BJ, Fittock M, Edwards KN, Carapetis JR. Long-term outcomes from acute rheumatic fever and rheumatic heart disease: a data-linkage and survival analysis approach. Circulation. 2016;134:222-232. doi: 10.1161/CIRCULATIONAHA.115.020966.
9. Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Joachim A, Daniels R, Francis V, Ogendo S, Gitura B, Mondo C, Okello E, Lwabi P, Al-Kebsi MM, Hugo-Hamman C, Sheta SS, Haileamlak A, Daniel W, Goshu DY, Abdissa SG, Desta AG, Shasho BA, Begna DM, ElSayed A, Ibrahim AS, Musuku J, Bode-Thomas F, Okeahialam BN, Ige O, Sutton C, Misra R, Abul Fadl A, Kennedy N, Damasceno A, Sani M, Ogah OS, Olunuga T, Elhassan HH, Mocumbi AO, Adeoye AM, Mntla P, Ojji D, Mucumbitsi J, Teo K, Yusuf S, Mayosi BM. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015;36:1115-122a. doi: 10.1093/eurheartj/ehu449.
10. Pelajo CF, Lopez-Benitez JM, Torres JM, de Oliveira SK. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr Rheumatol Online J. 2010;8:22. doi: 10.1186/1546-0096-8-22.
11. World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 29 October-1 November 2001. WHO Technical Report Series 2004.
12. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638. doi: 10.1086/313753.
13. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440-2492. doi: 10.1161/CIR.0000000000000029.
14. Kumar R, Raizada A, Aggarwal AK, Ganguly NK. A communitybased rheumatic fever/rheumatic heart disease cohort: twelveyear experience. Indian Heart J. 2002;54:54-58.
15. World Bank. World Bank Country and Lending Groups 2016. http://data.worldbank.org. Accessed October 17, 2016.
16. Günther G, Asmera J, Parry E. Death from rheumatic heart disease in rural Ethiopia. Lancet. 2006;367:391. doi: 10.1016/S0140-6736(06)68128-2.
17. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31:719-727. doi: 10.1093/eurheartj/ehp530.
18. Sharma J, Goel PK, Pandey CM, Awasthi A, Kapoor A, Tewari S, Garg N, Kumar S, Khanna R. Intermediate outcomes of rheumatic mitral stenosis post-balloon mitral valvotomy. Asian Cardiovasc Thorac Ann. 2015;23:923-930. doi: 10.1177/0218492315598240.
19. Yankah C, Fynn-Thompson F, Antunes M, Edwin F, Yuko-Jowi C, Mendis S, Thameur H, Urban A, Bolman R 3rd. Cardiac surgery capacity in Sub-Saharan Africa: quo vadis? Thorac Cardiovasc Surg. 2014;62:393-401. doi: 10.1055/s-0034-1383723.
20. Zühlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013;99:1554-1561. doi: 10.1136/heartjnl-2013-303896.
21. Watkins D, Zuhlke L, Engel M, Daniels R, Francis V, Shaboodien G, Kango M, Abul-Fadl A, Adeoye A, Ali S, Al-Kebsi M, Bode-Thomas F, Bukhman G, Damasceno A, Goshu DY, Elghamrawy A, Gitura B, Haileamlak A, Hailu A, Hugo-Hamman C, Justus S, Karthikeyan G, Kennedy N, Lwabi P, Mamo Y, Mntla P, Sutton C, Mocumbi AO, Mondo C, Mtaja A, Musuku J, Mucumbitsi J, Murango L, Nel G, Ogendo S, Ogola E, Ojji D, Olunuga TO, Redi MM, Rusingiza KE, Sani M, Sheta S, Shongwe S, van Dam J, Gamra H, Carapetis J, Lennon D, Mayosi BM. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué. Cardiovasc J Afr. 2016;27:1-5. doi: 10.5830/CVJA-2015-090.
22. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123:638-645.e4. doi: 10.1016/j.amjmed.2009.11.025.
23. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, Zhu J, Jansky P, Sigamani A, Morillo CA, Liu L, Damasceno A, Grinvalds A, Nakamya J, Reilly PA, Keltai K, Van Gelder IC, Yusufali AH, Watanabe E, Wallentin L, Connolly SJ, Yusuf S; RE-LY Atrial Fibrillation Registry Investigators. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RELY Atrial Fibrillation Registry. Circulation. 2014;129:1568-1576. doi: 10.1161/CIRCULATIONAHA.113.005451.
24. Kakkar N, Kaur R. Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution-a questionnaire survey. J Assoc Physicians India. 2004;52:868-872.
25. Kakkar N, Kaur R, John M. Outpatient oral anticoagulant management-an audit of 82 patients. J Assoc Physicians India. 2005;53:847-852.
26. Sharma P, Scotland G, Cruickshank M, Tassie E, Fraser C, Burton C, Croal B, Ramsay CR, Brazzelli M. The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-172.
27. Sharma P, Scotland G, Cruickshank M, Tassie E, Fraser C, Burton C, Croal B, Ramsay CR, Brazzelli M. Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation. BMJ Open. 2015;5:e007758. doi: 10.1136/bmjopen-2015-007758.
28. De Caterina R, John Camm A. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial. Europace. 2016;18:6-11. doi: 10.1093/europace/euv288.
29. Karthikeyan G, Mayosi BM. Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation. 2009;120:709-713. doi: 10.1161/CIRCULATIONAHA.108.836510.
30. Roberts K, Colquhoun S, Steer A, Reményi B, Carapetis J. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013;10:49-58. doi: 10.1038/nrcardio. 2012.157.
31. Zühlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep. 2013;15:343. doi: 10.1007/s11886-012-0343-1.
32. Manyemba J and Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3:CD002227.
33. Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, Damorou JM, Ndobo P, Menanga A, Kane A, Kakou-Guikahué M, Kenfack M, Metogo B, Chelo D, Yangnigni E, Tantchou C, Bertrand E, Monsuez JJ; Working Group on Tropical Cardiology of the Société française de cardiologie. The VALVAFRIC study: a registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016;109:321-329. doi: 10.1016/j. acvd.2015.12.004.
34. Robertson KA, Mayosi BM. Rheumatic heart disease: social and economic dimensions. S Afr Med J. 2008;98:780-781.
35. Sliwa K, Damasceno A, Davison BA, Mayosi BM, Sani MU, Ogah O, Mondo C, Ojji D, Dzudie A, Kouam CK, Yonga G, Ba SA, Ogola E, Edwards C, Milo O, Cotter G. Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF). Eur J Heart Fail. 2016;18:1248-1258. doi: 10.1002/ejhf.581
36. Zühlke L, Engel ME, Lemmer CE, van de Wall M, Nkepu S, Meiring A, Bestawros M, Mayosi BM. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study. BMC Cardiovasc Disord. 2016;16:46. doi: 10.1186/s12872-016-0225-3.